BIMI International Medical Inc. Common Stock

BIMI Stock Report Card

Today's performance

D

Performance

Score: 10/100

BIMI returned -75.58% in the last 12 months. Based on the other stocks in its sector with an average return of -6.46%, its performance is below average giving it a grade of 10 of 100.

Technicals

Score: 71/100

BIMI receives a 71 of 100 based on 14 indicators. 9 are bullish, 3 are bearish.

Profit

Score: 10/100

Out of the last 20 quarters, BIMI has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

Score: 45/100

BIMI has had a lower than average amount of volatility over the last 12 months giving it a grade of 45 of 100.

BIMI International Medical Inc. Common Stock Summary

Nasdaq / BIMI

Healthcare

Pharmaceutical Retailers

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.

Power up your portfolio

Build a portfolio of the best stocks

Pluto makes it easy to build investing strategies and automate your portfolio

See how

Checkout Similar Companies

BIMI scored poorly on our reportcard. Here are some similar companies and how they performed.

AstraZeneca PLC

$AZN Stock Report Card

Novo-Nordisk A/S

$NVO Stock Report Card

ContraFect Corporation

$CFRX Stock Report Card

PainReform Ltd. Ordinary Shares

$PRFX Stock Report Card

Phio Pharmaceuticals Corp. Common Stock

$PHIO Stock Report Card

Bluejay Diagnostics, Inc. Common Stock

$BJDX Stock Report Card

Intelligent Bio Solutions Inc. Common Stock

$INBS Stock Report Card

Xenetic Biosciences, Inc.

$XBIO Stock Report Card

View all stock report cards

Los Angeles, CA

Pluto is not a broker-dealer, investment adviser or member of FINRA. Securities offered by Alpaca Securities LLC (“Alpaca Securities”). Alpaca Securities is a member of FINRA and the Securities Investor Protection Corporation.

Alpaca Securities, LLC (“Alpaca Securities”) is not responsible for and is not providing the technology and services you receive from us to access and manage your brokerage account with Alpaca Securities. You firmly agree to hold Alpaca and its affiliates, owners, directors, employees, clearing firm and agents harmless for any loss or damage arising from the use of or unavailability of the technology and services that we are providing.

The content on this website is for informational purposes only. Pluto does not recommend any specific securities or investment strategies. Investing involves risk & investments may lose value, including the loss of principal. Past performance does not guarantee future results. Investors should consider their investment objectives and risks carefully before investing.